Clinical Trial

Faecal Analyses in Spondyloarthritis Therapy

Study acronym: FAST
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 6, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study evaluates the intestinal microbiome and disease activity in patients with spondyloarthropathies receiving immunosuppressive therapy. Patients will be analysed at two time points in reference to two predefined primary endpoints: * Changes in intestinal microbiome * Response to therapy The investigators want to evaluate if successful treatment of spondylarthropathy coincide with specific changes in the gut flora.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2019-02-12; most recent amendment 2024-03-05.
Trial Details
NCT Number NCT03839862
Lead Sponsor Region Skane
Conditions Spondyloarthropathies, Ankylosing Spondylitis
Enrollment 50 participants
Start Date 2019-01-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-03-06